Trials / Conditions / Recurrent Pleural Malignant Mesothelioma
Recurrent Pleural Malignant Mesothelioma
5 registered clinical trials studyying Recurrent Pleural Malignant Mesothelioma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Nintedanib in Treating Patients With Malignant Pleural Mesothelioma That Is Recurrent NCT02568449 | Barbara Ann Karmanos Cancer Institute | Phase 2 |
| Active Not Recruiting | Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelio NCT02535312 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Terminated | Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Active Not Recruiting | Pembrolizumab in Treating Patients With Malignant Mesothelioma NCT02399371 | University of Chicago | Phase 2 |